seen from Malaysia
seen from Australia
seen from Singapore
seen from India
seen from United States
seen from United States
seen from Philippines
seen from Israel
seen from United States
seen from France
seen from Switzerland
seen from Indonesia
seen from Türkiye
seen from Australia
seen from Hong Kong SAR China
seen from Türkiye
seen from Australia
seen from Australia
seen from United Kingdom
seen from Spain
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – World News Report – EIN News … Nasdaq Search Results
View On WordPress
Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
[unable to retrieve full-text content]
… , Inc. (“Millendo” or the “Company”) (Nasdaq: MLND), a clinical-stage biopharmaceutical … the Company in accordance with NASDAQ Listing Rule 5635(c)(4 …… Nasdaq Search Results
View On WordPress
Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
[unable to retrieve full-text content]
… , Inc. (“Millendo” or the “Company”) (Nasdaq: MLND), a clinical-stage biopharmaceutical … the Company in accordance with NASDAQ Listing Rule 5635(c)(4 …… Nasdaq Search Results
View On WordPress
Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
[unable to retrieve full-text content]
… , Inc. (“Millendo” or the “Company”) (Nasdaq: MLND), a clinical-stage biopharmaceutical … the Company in accordance with NASDAQ Listing Rule 5635(c)(4 …… Nasdaq Search Results
View On WordPress
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) – World News Report – EIN News <meta name="pubdate" content="2019-0... Nasdaq Search Results
View On WordPress
Synchronoss Technologies, Inc. Reports Inducement Grants to Employees Under Nasdaq Listing Rule 5635(c)(4)
Synchronoss Technologies, Inc. Reports Inducement Grants to Employees Under Nasdaq Listing Rule 5635(c)(4)
Synchronoss Technologies, Inc. Reports Inducement Grants to Employees Under Nasdaq Listing Rule 5635(c)(4) – World News Report – EIN News … Nasdaq Search Results
View On WordPress
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – World News Report – EIN News … Nasdaq Search Results
View On WordPress
Audentes Therapeutics grants stock options to six new employees under Nasdaq Listing Rule 5635(c)(4)
Audentes Therapeutics grants stock options to six new employees under Nasdaq Listing Rule 5635(c)(4)
Biotechnology company Audentes Therapeutics Inc (Nasdaq:BOLD) said on Friday that the board of directors’ compensation committee awarded equity awards to six newly appointed individuals in accordance with Nasdaq Listing Rule 5635(c)(4).
On the grant date of 7 March 2019, the employees received, in the aggregate, options to purchase 14,600 common stock from the company. The options have an…
View On WordPress
